1 | MPO, PON1
|
| Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.
|
| Huang Y, Wu Z, Riwanto M, Gao S, Levison BS, Gu X, Fu X, Wagner MA, Besler C, Gerstenecker G, Zhang R, Li XM, DiDonato AJ, Gogonea V, Tang WH, Smith JD, Plow EF, Fox PL, Shih DM, Lusis AJ, Fisher EA, DiDonato JA, Landmesser U, Hazen SL.
|
| J Clin Invest 123(9):3815-28. doi: 10.1172/JCI67478. Epub 2013 Aug 1.
2013
|
2 | ITGA2, PON1, THBS2
|
| Common polymorphisms in ITGA2, PON1 and THBS2 are associated with coronary atherosclerosis in a candidate gene association study of the Chinese Han population.
|
| Wang Y, Fu W, Xie F, Wang Y, Chu X, Wang H, Shen M, Wang Y, Wang Y, Sun W, Lei R, Yang L, Wu H, Foo J, Liu J, Jin L, Huang W.
|
| J Hum Genet 55(8):490-4. Epub 2010 May 20.PMID: 20485444 2010
|
3 | PON1, PON2, PON3
|
| Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer disease.
|
| Erlich PM, Lunetta KL, Cupples LA, Abraham CR, Green RC, Baldwin CT, Farrer LA.
|
| Neurobiol Aging eurobiol Aging. 2010 Oct 25. [Epub ahead of print]PMID: 20980077 2010
|
4 | PON1
|
| Paraoxonase activity might be predictive of the severity of aortic valve stenosis.
|
| Cagirci G, Cay S, Karakurt O, Durmaz T, Yazihan N, Canga A, Aydin C, Acikel S, Kilic H, Topaloglu S, Aras D, Demir AD, Akdemir R.
|
| J Heart Valve Dis 19(4):453-8.PMID: 20845892 2010
|
5 | PON1
|
| Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: a meta-analysis.
|
| Banerjee I.
|
| Eur J Epidemiol 25(7):449-58. Epub 2010 Jun 9.PMID: 20532959 2010
|
6 | PON1, PON2
|
| Paraoxonase gene polymorphisms and stroke severity.
|
| Lazaros L, Markoula S, Kyritsis A, Georgiou I.
|
| Eur J Neurol ur J Neurol. 2009 Nov 23. [Epub ahead of print]PMID: 19930448 2009
|
7 | PON1, PON2
|
| The roles of PON1 and PON2 in cardiovascular disease and innate immunity.
|
| Shih DM, Lusis AJ.
|
| Curr Opin Lipidol 20(4):288-92. Review.PMID: 19474728 2009
|
8 | PON1
|
| PON1 is a longevity gene: results of a meta-analysis.
|
| Lescai F, Marchegiani F, Franceschi C.
|
| Ageing Res Rev 8(4):277-84. Epub 2009 Apr 17. Review.PMID: 19376276 2009
|
9 | PON1
|
| Macrophage paraoxonase 1 (PON1) binding sites.
|
| Efrat M, Aviram M.
|
| Biochem Biophys Res Commun 376(1):105-10. Epub 2008 Aug 30.
2008
|
10 | AHCY, FOLH1, MTHFD1, MTR, NNMT, PON1, TYMS
|
| Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm.
|
| Giusti B, Saracini C, Bolli P, Magi A, Sestini I, Sticchi E, Pratesi G, Pulli R, Pratesi C, Abbate R.
|
| J Med Genet 45(11):721-30. Epub 2008 Jul 17.
2008
|
11 | PON1
|
| Paraoxonase 1 gene polymorphisms in patients with osteonecrosis of the femoral head with and without cerebral white matter lesions.
|
| Hadjigeorgiou GM, Malizos K, Dardiotis E, Aggelakis K, Dardioti M, Zibis A, Dimitroulias A, Scarmeas N, Tsezou A, Karantanas A.
|
| J Orthop Res 25(8):1087-93. 2007
|
12 | PON1, PON2, PON3
|
| Polymorphisms in the PON gene cluster are associated with Alzheimer disease.
|
| Erlich PM, Lunetta KL, Cupples LA, Huyck M, Green RC, Baldwin CT, Farrer LA; MIRAGE Study Group.
|
| Hum Mol Genet 15(1):77-85. Epub 2005 Nov 30. 2006
|
13 | PON1
|
| Paraoxonase-1 Q192R polymorphism and risk of sporadic amyotrophic lateral sclerosis.
|
| Slowik A, Tomik B, Partyka D, Turaj W, Pera J, Dziedzic T, Szermer P, Figlewicz DA, Szczudlik A.
|
| Clin Genet 69(4):358-9. No abstract available. 2006
|
14 | PON1
|
| Paraoxonase-1 expression is up-regulated in Down syndrome fetal liver.
|
| Janel N, Christophe O, A•t Yahya-Graison E, Hamelet J, Paly E, Prieur M, Delezo•de AL, Delabar JM.
|
| Biochem Biophys Res Commun 346(4):1303-6. Epub 2006 Jun 16. 2006
|
15 | FGF19, PON1
|
| A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids.
|
| Shih DM, Kast-Woelbern HR, Wong J, Xia YR, Edwards PA, Lusis AJ.
|
| J Lipid Res 47(2):384-92. Epub 2005 Nov 3. 2006
|
16 | PON1
|
| Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk.
|
| Baum L, Ng HK, Woo KS, Tomlinson B, Rainer TH, Chen X, Cheung WS, Chan DK, Thomas GN, Tong CS, Wong KS.
|
| Clin Biochem 39(3):191-5. Epub 2006 Feb 9. 2006
|
17 | PON1
|
| Paraoxonase 1 polymorphisms and survival.
|
| Christiansen L, Bathum L, Frederiksen H, Christensen K.
|
| Eur J Hum Genet 12(10):843-7. 2004
|
18 | PON1, PON2, PON3
|
| Human paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II.
|
| Robertson KS, Hawe E, Miller GJ, Talmud PJ, Humphries SE; Northwick Park Heart Study II.
|
| Biochim Biophys Acta 1639(3):203-12. 2003
|
19 | PON1
|
| Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm.
|
| Ito T, Yasue H, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, Mizuno Y, Kawano H, Ogawa H.
|
| Hum Genet 110(1):89-94. 2002
|
20 | PON1
|
| Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians.
|
| Bonafe M, Marchegiani F, Cardelli M, Olivieri F, Cavallone L, Giovagnetti S, Pieri C, Marra M, Antonicelli R, Troiano L, Gueresi P, Passeri G, Berardelli M, Paolisso G, Barbieri M, Tesei S, Lisa R, De Benedictis G, Franceschi C.
|
| Eur J Hum Genet 10(5):292-6. 2002
|
21 | PON1
|
| Human paraoxonase 1 gene polymorphisms and the risk of coronary heart disease: a community-based study.
|
| Watzinger N, Schmidt H, Schumacher M, Schmidt R, Eber B, Fruhwald FM, Zweiker R, Kostner GM, Klein W.
|
| Cardiology 98(3):116-22. 2002
|
22 | PON1
|
| Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration.
|
| Ikeda T, Obayashi H, Hasegawa G, Nakamura N, Yoshikawa T, Imamura Y, Koizumi K, Kinoshita S.
|
| Am J Ophthalmol 132(2):191-5. 2001
|
23 | PON1
|
| Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities.
|
| Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, Billicke S, Draganov D, Rosenblat M.
|
| Circulation 101(21):2510-7. 2000
|
24 | PON1
|
| Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.
|
| Jarvik GP, Rozek LS, Brophy VH, Hatsukami TS, Richter RJ, Schellenberg GD, Furlong CE.
|
| Arterioscler Thromb Vasc Biol 20(11):2441-7. 2000
|
25 | PON1
|
| Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
|
| Pfohl M, et al.
|
| Diabetes 48(3):623-7. 1999
|
26 | PON1
|
| Identification of residues essential for human paraoxonase (PON1) arylesterase/organophosphatase activities.
|
| Josse D, et al.
|
| Biochemistry 38(9):2816-25. 1999
|
27 | PON1
|
| Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects.
|
| Malin R, et al.
|
| Hum Genet 105(1-2):179-80. 1999
|
28 | PON1, PON2
|
| DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease.
|
| Sanghera DK, Aston CE, Saha N, Kamboh MI.
|
| Am J Hum Genet 62(1):36-44. 1998
|
29 | PON1
|
| the Met54Leu polymorphism of paraoxonase (PON) enzyme gene is not a genetic risk factor for non-insulin-dependent diabetes mellitus in Finns.
|
| Malin R, et al.
|
| Clin Genet 54 : 254-255. 1998
|
30 | PON1
|
| Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease.
|
| Kondo I, et al.
|
| Brain Res 806 : 271-273. 1998
|
31 | PON1
|
| The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan.
|
| Ko YL, et al.
|
| Atherosclerosis 141 : 259-264. 1998
|
32 | PON1, PON2, PON3
|
| The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.
|
| Primo-Parmo SL, et al.
|
| Genomics 33 : 498-507. 1996
|
33 | PON1
|
| Structural organization of the human PON1 gene.
|
| Clendenning JB, et al.
|
| Genomics 35 : 586-589. 1996
|
34 | PON1
|
| The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
|
| Davies HG, et al.
|
| Nat Genet 14(3):334-6 1996
|
35 | NIDDM5, PON1
|
| Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.
|
| Ruiz J, et al.
|
| Lancet 346 : 869-872. 1995
|
36 | PON1
|
| Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase : glutamine or arginine at position 191, for the respective A or B allozymes.
|
| Adkins S, et al.
|
| Am J Hum Genet 52 : 598-608. 1993
|
37 | PON1
|
| The molecular basis of the human serum paraoxonase activity polymorphism.
|
| Humbert R, et al.
|
| Nat Genet 3 : 73-76. 1993
|
38 | PON1
|
| The human serum paraoxonase/arylesterase polymorphism.
|
| La Du BN.
|
| Am J Hum Genet 43 : 227-229. 1988
|
39 | PON1
|
| Number of loci responsible for the inheritance of high and low activity of paraoxonase.
|
| Nielsen A, et al.
|
| Clin Genet 29 : 216-221. 1986
|
40 | CFTR, PON1
|
| Linkage between the loci for cystic fibrosis and paraoxonase.
|
| Schmiegelow K, et al.
|
| Clin Genet 29 : 374-377. 1986
|
41 | PON1
|
| Linkage relationships of paraoxonase (PON) with other markers: indication of PON-cystic fibrosis synteny.
|
| Eiberg H, et al.
|
| Clin Genet 28 : 265-271. 1985
|